Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 19Small Cell Lung Carcinoma 10Lung Neoplasms 10Squamous Cell Carcinoma of Head and Neck 8Cholangiocarcinoma 7Pancreatic Neoplasms 6Ovarian Neoplasms 6Oropharyngeal Neoplasms 6Fallopian Tube Neoplasms 6Urinary Bladder Neoplasms 5Breast Neoplasms 5Uterine Cervical Neoplasms 4Gallbladder Neoplasms 4Brain Neoplasms 4Adenocarcinoma of Lung 4Stomach Neoplasms 3Sarcoma 3Mouth Neoplasms 3Mesothelioma, Malignant 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Carcinoma 3Urethral Neoplasms 2Triple Negative Breast Neoplasms 2Testicular Neoplasms 2Seminoma 2Salivary Gland Neoplasms 2Recurrence 2Prostatic Neoplasms 2Peritoneal Neoplasms 2

Interventions

lutetium Lu 177 dotatate 29Everolimus 19Temozolomide 11gallium Ga 68 dotatate 10Nivolumab 10Magnetic Resonance Spectroscopy 10Capecitabine 9pembrolizumab 8lanreotide 8Positron Emission Tomography Computed Tomography 8cabozantinib 73-Iodobenzylguanidine 7177Lu-octreotide, DOTA(0)-Tyr(3)- 7Somatostatin 690Y-octreotide, DOTA-Tyr(3)- 6telotristat ethyl 5lenvatinib 5Octreotide 5Lutetium-177 5Ga(III)-DOTATOC 5Fluorodeoxyglucose F18 5Carboplatin 5avelumab 4Positron-Emission Tomography 4Ipilimumab 4Bevacizumab 4surufatinib 3pasireotide 3fluorodopa F 18 3copper dotatate CU-64 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neuroendocrine Tumors × Platinum × Clear all
NCT02402920 2026-03-10

Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
83 enrolled 13 charts
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡